|
| Resources |
| Below are some resources about Restless Legs Syndrome (RLS) for you and your patients. This Web site contains links to third-party Restless Legs Syndrome sites on the Internet. These links are provided as a service to patients and healthcare professionals interested in additional information about Restless Legs Syndrome. These sites are not a part of this GlaxoSmithKline Web site. The content and materials in these third-party Web sites are not necessarily produced by nor endorsed by GlaxoSmithKline and may refer to uses for products that are not included in the FDA-approved prescribing information for those products. Patients should always consult with their physician or healthcare professional before beginning any treatment program. |
| Web Sites |
Restless Legs Syndrome Foundation
The RLS Foundation is a nonprofit agency dedicated to improving the lives of men, women, and children who live with this disruptive disease. The organization's goals are to increase awareness of RLS and support research. The RLS Foundation Web site includes contact information for local patient support groups around the country.
www.rls.org
819 Second St. SW
Rochester, MN 55902-2985
Tel: (507) 287-6465
Fax: (507) 287-6312
WE MOVE™: Worldwide Education & Awareness for Movement Disorders
WE MOVE™ is a not-for-profit organization founded in 1991 to educate and inform patients, professionals and the public about neurologic movement disorders, including RLS.
www.wemove.org
204 W. 84th St.
New York, NY 10024
Tel: (212) 875-8312
Fax: (212) 875-8389
National Sleep Foundation
The National Sleep Foundation (NSF) is an independent nonprofit organization dedicated to improving public health and safety by achieving an understanding of sleep and sleep disorders, and by supporting education, and sleep-related research and advocacy.
www.sleepfoundation.org
1522 K St, NW, Suite 500
Washington, DC 20005
Tel: (202) 347-3471
Fax: (202) 347-3472
National Heart, Lung, and Blood Institute (NHLBI)
NHLBI is part of the National Institutes of Health and supports research into diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. NHLBI offers a downloadable RLS Fact Sheet that can also be ordered as a printed version online, by phone, or by mail.
www.nhlbi.nih.gov/health/public/sleep/rls.htm
NHLBI Health Information Center
P.O. Box 30105
Bethesda, MD 20824-0105
Tel: (301) 592-8573
Fax: (301) 592-8563
TTY (for people using adaptive equipment): (240) 629-3255
National Institute of Neurological Disorders and Stroke (NINDS)
NINDS is part of the National Institutes of Health and supports biomedical research on disorders of the brain and nervous system. The NINDS RLS Information Page offers an overview of RLS and links to additional publications and resources. www.ninds.nih.gov/health_and_medical/disorders/restless_doc.htm
NIH Neurological Institute
P.O. Box 5801
Bethesda, MD 20824-5801
Tel: (800) 352-9424 or (301) 496-5751
TTY (for people using adaptive equipment): (301) 468-5981
|
Requip is indicated for patients with moderate-to-severe primary RLS.
Requip has been associated with sedating effects, including somnolence, and the possibility of falling asleep while engaged in activities of daily living, including operation of a motor vehicle. Syncope or symptomatic hypotension may occur, particularly during initial treatment or dose titration. Impulse control symptoms, including pathological gambling and hypersexuality, have been reported in patients treated with dopaminergic agents, including ropinirole.
For More Safety Information about Requip, click here.
Complete Prescribing Information for Requip® (ropinirole HCl) Tablets
|
This site is intended for US healthcare professionals only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us
|
|
|
Resources
